GERN

MKT CAP:$776M

Geron Corporation

Market Cap

$776M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.13-$0.19 (-14.39%)

Jun 8, 2026

52W High $1.9552W Low $1.07

Company Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients wi...

CEO

—

IPO Date

Jun 30, 1996

Website

www.geron.com

Key Metrics TTM

Revenue

$196M

+68.6% YoY

Net Income

-$70M

EPS (Diluted)

Free Cash Flow

-$126M

Revenue / Share

$0.29

Gross Margin

86.6%

Operating Margin

-19.1%

Net Margin

-35.5%

FCF Margin

-64.4%

P/S

4.0x

P/E

Earnings Reports

Q1 2026

May 6, 2026

$52M+30.9%

FY 2025

Mar 2, 2026

$184M+138.8%

Q4 2025

Mar 2, 2026

$48M+1.0%

Q3 2025

Nov 7, 2025

$47M+67.1%

Q2 2025

Aug 6, 2025

$49M+5459.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee